Evidence map›Paper›PMID 41788361›Full record

ArticleCrohn's & colitis 3602026

Erythema nodosum as a marker for objective disease activity in inflammatory bowel disease.

Solomon Sasson, Itay Kalisky, Gregory Rosenfeld, Jeremy Liu Chen Kiow, Brian Bressler

Abstract read
In one paragraph

Article in Crohn's & colitis 360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Solomon SassonUniversity of British Columbia, Vancouver, Canada.ORCID https://orcid.org/0009-0008-2137-6054
Itay KaliskyDivision of Gastroenterology, The IBD Centre of British Columbia.
Gregory RosenfeldDivision of Gastroenterology, The IBD Centre of British Columbia.
Jeremy Liu Chen KiowDivision of Gastroenterology, Department of Medicine, Montreal University Hospital Centre (CHUM), Montreal, Quebec, Canada.
Brian BresslerDivision of Gastroenterology, The IBD Centre of British Columbia.ORCID https://orcid.org/0000-0003-4740-8209

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Erythema nodosum (EN) is an inflammatory condition marked by tender, red nodules, typically on the extensor limbs. Though often linked to IBD activity, its association with objective markers like inflammatory labs or endoscopic findings remains unclear. This study examined the relationship between EN and objective inflammation in IBD patients. Methods: At a tertiary clinic with over 6500 patients, individuals with active EN were identified. Patients with active EN were identified, and symptomatic disease activity was assessed. Objective assessments included endoscopy, cross-sectional imaging (CT/MRI), fecal calprotectin, and CRP. Descriptive statistics compared objective and subjective disease activity in relation to EN. Results: Of 169 patients with documented EN, 95 had at least one objective assessment within our timeframe and were included. The mean age at EN presentation was 32 years; most had Crohn's disease (80%) and were female (75%). Among CD patients, 93% had colonic involvement and 32% had penetrating disease. A total of 77 (74%) patients had gastrointestinal symptoms at the time of EN presentation, and 84 (81%) had objective evidence of active disease. Endoscopy was performed in 66% of cases, with 58 patients (84%) showing active inflammation. Among CD patients, 53% had mucosal ulcerations, while 67% of UC patients had severe disease (Mayo E3). Conclusions: In this cohort, most patients presenting with EN had both symptomatic and objective signs of intestinal inflammation. These findings support the use of objective testing in IBD patients with EN and suggest EN may indicate a more severe or complicated disease course.

Indexed as

endoscopic activityerythema nodosumextraintestinal manifestationsinflammatory bowel disease

Identifiers

PMID41788361
PMCPMC12958114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.